摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (R)-3-(tert-butyldimethylsilyloxy)dodecanoate | 913655-54-6

中文名称
——
中文别名
——
英文名称
methyl (R)-3-(tert-butyldimethylsilyloxy)dodecanoate
英文别名
methyl (3R)-3-[tert-butyl(dimethyl)silyl]oxydodecanoate
methyl (R)-3-(tert-butyldimethylsilyloxy)dodecanoate化学式
CAS
913655-54-6
化学式
C19H40O3Si
mdl
——
分子量
344.61
InChiKey
TVNMNDKWJIYIAP-QGZVFWFLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.08
  • 重原子数:
    23
  • 可旋转键数:
    14
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (R)-3-(tert-butyldimethylsilyloxy)dodecanoate二异丁基氢化铝 作用下, 以 二氯甲烷 为溶剂, 以86%的产率得到(3R)-3-[tert-butyl(dimethyl)silyl]oxytridecanal
    参考文献:
    名称:
    BETA-LACTONE COMPOUNDS
    摘要:
    本发明提供具有一般结构A的化合物,或其药学上可接受的衍生物:其中R是烷基基团,R1包括至少一种从烷基、烯基、芳基、杂环、羟基、酯、酰胺、醛基和卤素组成的基团。
    公开号:
    US20090124681A1
  • 作为产物:
    描述:
    L-苹果酸二甲酯叔丁基锂 作用下, 以 乙醚 为溶剂, 反应 4.5h, 生成 methyl (R)-3-(tert-butyldimethylsilyloxy)dodecanoate
    参考文献:
    名称:
    Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    摘要:
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
    DOI:
    10.1021/ol061651o
点击查看最新优质反应信息

文献信息

  • Asymmetric Synthesis of Sphinganine and Clavaminol H
    作者:Ramzi Ait-Youcef、Xavier Moreau、Christine Greck
    DOI:10.1021/jo1003899
    日期:2010.8.6
    An efficient enantioselective synthesis of sphinganine and clavaminol H is reported. These sphingoid-type bases were obtained from commercially available fatty acids using highly enantioselective Ru-catalyzed hydrogenation and organocatalytic electrophilic amination reactions to create the stereogenic centers.
    报道了一种有效的对映体选择性合成斯潘加宁和卡瓦米酚H的方法。这些鞘氨醇型碱是通过使用高度对映选择性的Ru催化的氢化反应和有机催化的亲电胺化反应从立体异构中心获得的,可从市售脂肪酸中获得。
  • Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
    作者:Robyn D. Richardson、Gil Ma、Yatsandra Oyola、Manuel Zancanella、Lynn M. Knowles、Piotr Cieplak、Daniel Romo、Jeffrey W. Smith
    DOI:10.1021/jm800321h
    日期:2008.9.11
    Fatty acid synthase (FAS) is necessary for growth and survival of tumor cells and is a promising drug target for oncology. Here, we report oil the syntheses and activity of novel inhibitors of the thioesterase domain of FAS. Using the structure of orlistat as a starting point, which contains a beta-lactone as the central pharmacophore, 28 novel congeners were synthesized and examined. Structural features such as the length of the alpha- and beta-alkyl chains, their chemical composition, and arnino ester substitutions were altered and tile resulting compounds explored for inhibitory activity toward the thioesterase domain of FAS. Nineteen congeners show improved potency for FAS in biochemical assays relative to orlistat. Three of that subset, including the natural product valilactone, also display all increased potency in inducing tumor cell death and improved solubility compared to orlistat. These findings Support the idea that all orlistat congener can be optimized for use in a preclinical drug design and for clinical drug development.
  • Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    作者:Gil Ma、Manuel Zancanella、Yatsandra Oyola、Robyn D. Richardson、Jeffrey W. Smith、Daniel Romo
    DOI:10.1021/ol061651o
    日期:2006.9.1
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
  • BETA-LACTONE COMPOUNDS
    申请人:Smith Jeffrey W.
    公开号:US20090124681A1
    公开(公告)日:2009-05-14
    The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R 1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.
    本发明提供具有一般结构A的化合物,或其药学上可接受的衍生物:其中R是烷基基团,R1包括至少一种从烷基、烯基、芳基、杂环、羟基、酯、酰胺、醛基和卤素组成的基团。
查看更多